4-aminopyridine has been researched along with Idiopathic Parkinson Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bancroft, EA | 1 |
| De La Mora, M | 1 |
| Pandey, G | 1 |
| Zarate, SM | 1 |
| Srinivasan, R | 1 |
| Shi, L | 1 |
| Jia, L | 1 |
| Wang, Y | 1 |
| Xiu, M | 1 |
| Xie, J | 1 |
| Li, S | 1 |
| Wei, D | 1 |
| Mao, Z | 1 |
| Chen, L | 1 |
| Yan, X | 1 |
| Li, Y | 1 |
| Dong, S | 1 |
| Wang, D | 1 |
| Luca, CC | 3 |
| Nadayil, G | 1 |
| Dong, C | 1 |
| Nahab, FB | 1 |
| Field-Fote, E | 1 |
| Singer, C | 3 |
1 review available for 4-aminopyridine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Can 4-aminopyridine modulate dysfunctional gait networks in Parkinson's disease?
Topics: 4-Aminopyridine; Animals; Gait; Humans; Nerve Net; Neurons; Parkinson Disease; Potassium Channel Blo | 2013 |
1 trial available for 4-aminopyridine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial.
Topics: 4-Aminopyridine; Aged; Cross-Over Studies; Double-Blind Method; Female; Follow-Up Studies; Gait; Hum | 2017 |
4 other studies available for 4-aminopyridine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Extracellular S100B inhibits A-type voltage-gated potassium currents and increases L-type voltage-gated calcium channel activity in dopaminergic neurons.
Topics: 4-Aminopyridine; Animals; Calcium; Calcium Channels, L-Type; Dopaminergic Neurons; Male; Mice; Parki | 2022 |
4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 4-Aminopyridine; Animals; Disease Models, Animal; Dopa | 2023 |
Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease.
Topics: 4-Aminopyridine; alpha-Synuclein; Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Dose- | 2017 |
4-aminopyridine improves freezing of gait in Parkinson's disease.
Topics: 4-Aminopyridine; Follow-Up Studies; Gait Disorders, Neurologic; Humans; Male; Parkinson Disease; Pot | 2013 |